Article
Efavirenz therapy in rhesus macaques infected with a chimera of simian immunodeficiency virus containing reverse transcriptase from human immunodeficiency virus type 1.
Antimicrobial agents and chemotherapy - 1 Sept 2004
Hofman Michael J, Higgins Joanne, Matthews Timothy B, Pedersen Niels C, Tan Chalet, Schinazi Raymond F, North Thomas W
Abstract excerpt
The specificity of nonnucleoside reverse transcriptase (RT) inhibitors (NNRTIs) for the RT of human immunodeficiency virus type 1 (HIV-1) has prevented the use of simian immunodeficiency virus (SIV) in the study of NNRTIs and NNRTI-based highly active antiretroviral therapy. However, a SIV-HIV-1 chimera (RT-SHIV), in which the RT from SIVmac239 was replaced with the RT-encoding region from HIV-1, is susceptible...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
